Report Top Up a Page Previous Next Up a Map TOC Page Index File Index What's New Page Bottom
Cognigen Corporation - Posters and Presentations : Pre-2006 : 2002 : IDSA 2002 published Mon, Nov 10, 2008 - 15:27 EST

IDSA 2002

idsa_logo_171023402_146.gif

Name Type Description
Relationships Between Susceptibility of Streptococcus pneumoniae against Levofloxacin & Hospital- & Patient-Specific Variables: Report from the Antimicrobial Resistance Rate Epidemiology Study Team (ARREST Program) PDF Page Primary Author: Sujata M. Bhavnani, M.S., Pharm.D.
Gatifloxacin and the Elderly: PK-PD Rationale for Potential Age-Related Dose Reduction PDF Page Primary Author: Paul G. Ambrose
Minimum Efficacy and Mutation Prevention Exposure Target Attainment Rates Against Streptococcus pneumoniae for Levofloxacin 500 mg and 750 mg and Moxifloxacin 400 mg PDF Page Primary Author: RC Owens; Primary Cognigen Author: Paul G. Ambrose
Pharmacodynamics of Gatifloxacin 400 mg, Levofloxacin 500 mg and 750 mg and Moxifloxacin 400 mg Against Ciprofloxacin-Resistant Streptococcus pneumoniae PDF Page Primary Author: RC Owens; Primary Cognigen Author: Paul G. Ambrose
Pharmacokinetics/Pharmacodynamics in Otitis Media: Comparison of Time-Dependent Antibiotics in Middle Ear Fluid PDF Page Primary Author: Sujata M. Bhavnani
Page authored by Cognigen Corporation

Cognigen Corporation - Posters and Presentations : Pre-2006 : 2002 : IDSA 2002 published Mon, Nov 10, 2008 - 15:27 EST
Report Top Up a Page Previous Next Up a Map TOC Page Index File Index What's New Page Top